Brenner v. Manson

383 U.S. 519 (1966)

  • Manson was a chemist who invented a new process for manufacturing a type of steroid. He applied for a patent for his process.
  • The patent examiner denied the patent. Manson appealed.
    • The patent examiner found that the chemicals Manson was making with his process had no utility, and you can't get a patent for making something that's totally useless.
    • Manson argued that several similar steroids were undergoing screening as possible cancer drugs.
  • The Board of Appeals affirmed the decision. Manson appealed to the Court of Customs and Patent Appeals.
    • "It is our view that the Statutory requirement of usefulness of a product cannot be presumed merely because it happens to be closely related to another compound which is known to be useful."
  • The Court of Customs and Patent Appeals (CCPA) reversed. The US Patent Office appealed (through their Commissioner, Brenner)
    • The CCPA found that it is not necessary to show utility for a product, you just have to show that it isn't detrimental to the public interest.
  • The US Supreme Court reversed.
    • The US Supreme Court went back to the language of the original 1790 patent law which said, "whoever invents or discovers any new and useful process, machine…may obtain a patent therefore…"
    • Manson argued over what the term useful meant. Should it be read to mean that the process he invented was useful in created the intended steroid? Or did it mean that the steroid that the process produced was useful?
      • Manson had invented a useful process for producing a useless chemical.
    • The US Supreme Court felt that giving Manson a patent for a process to produce a chemical with no known uses would discourage others from trying to find a use for that chemical.
      • A patent gives the owner a monopoly. In order to deserve that monopoly you have to show that your idea is really useful to society.
      • On the other hand, granting a patent would certainly encourage the inventor to look for a use for the product, wouldn't it?
  • In a dissent, it was argued that chemistry is an inexact science and has many interrelated fields. It's not always possible to know exactly what commercial applications are going to appear when a new chemical or process is invented. By denying Manson's patent, the Court is actually discouraging research into potential applications for the steroid.
    • There was a commercial market for the steroid. Research scientists bought it for their research. Isn't that useful?